Volume 17, Issue 5, Pages (May 2009)

Slides:

Advertisements

Similar presentations

A Role for Dystroglycan in Basement Membrane Assembly Michael D Henry, Kevin P Campbell Cell Volume 95, Issue 6, Pages (December 1998) DOI: /S (00)

Advertisements

Volume 20, Issue 2, (February 2012)

414. A Novel Clinical Severity Scoring Measure in Canine X-Linked Myotubular Myopathy: Results Following Systemic AAV Gene Replacement Molecular Therapy

209. Use of Helicobacter pyroli Neutrophil Activating Protein (NAP) as an Immune- Modulatory Agent To Enhance the Efficacy of Oncolytic Adenovirus Therapy.

Statistical Considerations for Immunohistochemistry Panel Development after Gene Expression Profiling of Human Cancers Rebecca A. Betensky, Catherine.

446. Gender Differences in the Osteogenic & Chondrogenic Potential of Human Muscle- Derived Stem Cells In Vitro Alex C. Scibetta, Andrea B. Liebowitz,

Man's Best Friend: Utilizing Naturally Occurring Tumors in Dogs to Improve Chimeric Antigen Receptor T-cell Therapy for Human Cancers Melinda Mata, Stephen.

Noncardiac Chest Pain Clinical Gastroenterology and Hepatology

Volume 111, Issue 7, Pages (October 2016)

Genome-editing Technologies for Gene and Cell Therapy

627. Non-Invasive, Multimodal Imaging of Microvesicles with Metabolically Biotinylated, Membrane-Bound Gaussia Luciferase Molecular Therapy Volume.

Elizabeth Morris, Alex Scibetta, Aiping Lu, Xueqin Gao, Johnny Huard

Volume 24, Issue 11, Pages (November 2016)

162. Stability of Polymer/Plasmid DNA Complexes In Vitro and In Vivo

281. Rapid Generation of Induced Pluripotent Stem Cells (iPSCs) from the Urine of a Patient with Duchenne Muscular Dystrophy Molecular Therapy Volume.

Hydrodynamic Gene Delivery: Its Principles and Applications

Direct Conversion of Skin Cells into Blood: Alchemy or Science?

Molecular Therapy Volume 20, Pages S261-S262 (May 2012) DOI: /S (16)

Evolving Gene Therapy in Primary Immunodeficiency

In Vivo Gene Delivery by Nonviral Vectors: Overcoming Hurdles?

Volume 20, Issue 6, Pages (June 2012)

343. Benchtop DNA Synthesizer: Oligo-Templated Polymerization (OTP)

Gene electrotransfer: Potential for gene therapy of renal diseases

637. Effect of PEG Grafting Degree on Morphology and Transfection Efficiency of Polycation-g-PEG/DNA Nanoparticles Molecular Therapy Volume 20, (May.

Escaping the Valley of Death

Volume 20, Issue 1, Pages (January 2012)

John R. Martin, Christopher E. Nelson, Mukesh K

Volume 26, Issue 2, Pages (February 2018)

Xiuyan Wang, Isabelle Rivière Molecular Therapy - Oncolytics

A Theranostic “SMART” Aptamer for Targeted Therapy of Prostate Cancer

The Other Face of Chimeric Antigen Receptors

724. Blood-Derived Endothelial Progenitor Cells Can Be Isolated With a Novel Method of Diluted Whole Blood Incubation with AMD3100-Induced Mobilization.

Genome-editing Technologies for Gene and Cell Therapy

Valder R Arruda, Patricia Favaro, Jonathan D Finn Molecular Therapy

Premal Lulla, Carlos A. Ramos Molecular Therapy

Molecular Therapy Volume 20, (May 2012) DOI: /S (16)

Molecular Therapy Volume 7, Issue 5, (May 2003) DOI: /S (16)

547. AAV Preparations Contain Contamination from DNA Sequences in Production Plasmids Directly Outside of the ITRs Mark A. Brimble, Junfang Zhou, Christopher.

Adenovirus Virion Stability and the Viral Genome: Size Matters

847. Eradication of Therapy-Resistant Human Prostate Tumors Using an Ultrasound Guided Site-Specific Cancer Terminator Virus Delivery Approach Molecular.

611. Alpha-Dystrobrevin-3 Prevents Myopathy and Restores Diaphragm Function in the Alpha-Dystrobrevin Null Mouse Guy L. Odom, Glen B. Banks, Marvin E.

Designer Lipids Advance Systemic siRNA Delivery

Volume 20, Issue 6, Pages (June 2012)

133. Survival with Normal Neurological Development of the Juvenile Lethal Urea Cycle Defect Arginase Deficient Mouse with AAV Gene Therapy Molecular.

660. Bowel/Bladder Sensation and Control in Patients with Spinal Cord Injury Treated with Human Embryonic Stem Cell Therapy Geeta Shroff Molecular Therapy

68. Site Specific Intra-Placental Gene Transfer Corrects Fetal Growth Restriction in a Novel Mouse Model of Placental Insufficiency (PI) Molecular.

521. Multiplex Genome Editing of TCR°/CD52 Genes as a Platform for “Off the Shelf” Adoptive T-Cell Immunotherapies Molecular Therapy Volume 22, Pages.

Volume 18, Issue 2, Pages (February 2010)

Chae-lyul Limg, Yeon-Ju Lee, Sujeong Kim

335. High Content Analysis Platform for Optimization of Lipid Mediated CRISPR-Cas9 Delivery Strategies in Human Cells Benjamin Steyer, Jared Carlson-Stevermer,

405. Hindlimb and Forelimb Strength Assessment in a Canine Model of X-Linked Myotubular Myopathy Following AAV-Mediated Gene Replacement Molecular.

Volume 26, Issue 4, Pages (April 2018)

674. Molecular, Biochemical and Biomechanical Analysis of Articular Cartilage Repaired with Genetically Modified Chondrocytes Expressing Insulin-Like.

Molecular Therapy Volume 18, Pages S260-S261 (May 2010) DOI: /S (16)

In This Issue Molecular Therapy Volume 16, Issue 4, (April 2008)

372. Targeted Mutagenesis of Ubiquitin-Binding Lysine Residues on the Adeno- Associated Virus (AAV)2 Capsid Improves Its Transduction Efficiency Molecular.

521. AAV Immunotherapy Induces Functional Antigen Specific Regulatory T-Cells to a Neuroantigen: A Potential Treatment for MS Brad E. Hoffman Molecular.

483. In Vivo DMD Gene Editing in Muscles and Muscle Stem Cells of Dystrophic Mice Mohammadsharif Tabebordbar, Kexian Zhu, Jason Cheng, Jeffrey Widrick,

Rajendra N. Mitra, Min Zheng, Zongchao Han

773. Detection of RNA Interference (RNAi) Mediated mRNA Cleavage in Fresh Injected Tumor Tissue from Patients in a Phase I Trial of pbi-shRNA™ Lipoplex.

740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells Molecular Therapy Volume 20, Pages S285-S286.

Molecular Therapy Volume 21, Pages S247-S248 (May 2013)

Shigeki Yagyu, Malcolm K. Brenner

History of Oncolytic Viruses: Genesis to Genetic Engineering

86. A Highly Compact Epitope-Based Marker Suicide Gene for Safer and Easier Adoptive T-Cell Gene Therapy Molecular Therapy Volume 20, Pages S35-S36.

Kazim H Narsinh, Jordan Plews, Joseph C Wu Molecular Therapy

297. Minimally Invasive Implantation of Autologous Chondrocytes Transduced with rAAV5-IGF-I Improves Longterm Cartilage Repair in Full-Thickness Chondral.

Sensing Bad: Are Co-stimulatory CAR-Expressing γδ T Cells Safer?

Shirley Wong, Roderick A. Slavcev

624. Randomized Phase II Trial of Adjuvant Autologous Tumor Cell Vaccine (FANG™) for High Risk Stage III/IV Ovarian Cancer: Preliminary Results Molecular.

Presentation transcript:

Volume 17, Issue 5, Pages 922-928 (May 2009) Tolerability of Two Sequential Electroporation Treatments Using MedPulser DNA Delivery System (DDS) in Healthy Adults Mark Wallace, Barbara Evans, Sandra Woods, Robin Mogg, Lei Zhang, Adam C Finnefrock, Dietmar Rabussay, Michael Fons, John Mallee, Devan Mehrotra, Florian Schödel, Luwy Musey Molecular Therapy Volume 17, Issue 5, Pages 922-928 (May 2009) DOI: 10.1038/mt.2009.27 Copyright © 2009 The American Society of Gene Therapy Terms and Conditions

Figure 1 MedPulser DDS device and formation of transient pores in cell membrane following electroporation. Molecular Therapy 2009 17, 922-928DOI: (10.1038/mt.2009.27) Copyright © 2009 The American Society of Gene Therapy Terms and Conditions

Figure 2 DNA vaccination and schematic representation of the effect of electroporation at the cell membrane level. Molecular Therapy 2009 17, 922-928DOI: (10.1038/mt.2009.27) Copyright © 2009 The American Society of Gene Therapy Terms and Conditions

Figure 3 CONSORT chart: subject disposition. †One subject experienced a vasovagal reaction and one subject reported prolonged local pain after treatment with MedPulser DDS. Molecular Therapy 2009 17, 922-928DOI: (10.1038/mt.2009.27) Copyright © 2009 The American Society of Gene Therapy Terms and Conditions